Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00262977 · ClinicalTrials.gov registry record · NA

Improving Aspirin Use in Diabetes: A Cluster Randomized Trial

A NA study of Diabetes Mellitus, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT00262977: Completed NA study of Diabetes Mellitus, sponsored by Northwestern University.

NCT00262977 is a NA study of Diabetes Mellitus that has completed, run by Northwestern University. The registered enrollment target is 300 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00262977, a NA study of Diabetes Mellitus, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Our aim is to determine if a patient-directed intervention is more effective than computerized clinician reminders alone for improving aspirin use in adults with diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Electronic prompt plus patient-directed intervention
  • BEHAVIORAL Electronic prompt to clinician to prescribe aspirin

Study Locations (1)

Illinois

  • Northwestern University, Division of General Internal Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2004-09
Est. Completion 2005-05
Phase NA
Northwestern University

1,209 total trials

What the finished NCT00262977 record still lists

NCT00262977 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Electronic prompt plus patient-directed intervention is the first listed.

NCT00262977 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00262977 about?

NCT00262977 is a clinical study titled "Improving Aspirin Use in Diabetes: A Cluster Randomized Trial". Our aim is to determine if a patient-directed intervention is more effective than computerized clinician reminders alone for improving aspirin use in adults with diabetes.

What is the current status of trial NCT00262977?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2004-09. Estimated completion is 2005-05.

What conditions does trial NCT00262977 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00262977?

The interventions under investigation include: Electronic prompt plus patient-directed intervention (BEHAVIORAL), Electronic prompt to clinician to prescribe aspirin (BEHAVIORAL).

Who is sponsoring clinical trial NCT00262977?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00262977 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00262977's enrollment target sits among peer trials

300 66th of 208 higher than 141 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00262977, the US trial registry maintained by the National Library of Medicine. NCT00262977 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.